These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 5892858)

  • 1. Phenylketonuria or phenylpyruvic oligophrenia in the rat: behavioural and biochemical correlates.
    Perez VJ
    J Ment Defic Res; 1965 Sep; 9(3):170-82. PubMed ID: 5892858
    [No Abstract]   [Full Text] [Related]  

  • 2. Aminoaciduria and mental retardation. II. Phenylpyruvic oligophrenia, phenylketonuria (PKU).
    ZELLWEGER H
    J Iowa State Med Soc; 1961 Aug; 51():536-40. PubMed ID: 13788179
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on conversion of phenylalanine to tyrosine in phenylpyruvic oligophrenia.
    WALLACE HW; MOLDAVE K; MEISTER A
    Proc Soc Exp Biol Med; 1957 Apr; 94(4):632-3. PubMed ID: 13431902
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenylalanine metabolism in the phenylpyruvic condition. I. Distribution, pool size, and turnover rate in human phenylketonuria.
    GRUMER HD; KOBLET H; WOODARD C
    J Clin Invest; 1961 Sep; 40(9):1758-65. PubMed ID: 13709234
    [No Abstract]   [Full Text] [Related]  

  • 5. [Some experiments on phenylalanine- and tyrosine metabolism in a patient with phenylpyruvic oligophrenia].
    HAMANN I
    Maandschr Kindergeneeskd; 1956 Jan; 24(1):28-36. PubMed ID: 13308279
    [No Abstract]   [Full Text] [Related]  

  • 6. [Investigations of phenylalanine and tyrosine metabolism in a child with phenylpyruvic oligophrenia].
    HAMANN I
    Z Kinderheilkd; 1956; 78(2):177-84. PubMed ID: 13423485
    [No Abstract]   [Full Text] [Related]  

  • 7. The hydroxylation of phenylalanine and antipyrine in phenylpyruvic oligophrenia.
    UDENFRIEND S; BESSMAN SP
    J Biol Chem; 1953 Aug; 203(2):961-6. PubMed ID: 13084666
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of 5-hydroxytryptophan decarboxylase by phenylalanine metabolites.
    DAVISON AN; SANDLER M
    Nature; 1958 Jan; 181(4603):186-7. PubMed ID: 13504122
    [No Abstract]   [Full Text] [Related]  

  • 9. The dietary phenylalanine requirements and tolerances of phenylketonuric patients.
    PAINE RS; HSIA DY
    AMA J Dis Child; 1957 Sep; 94(3):224-30. PubMed ID: 13457650
    [No Abstract]   [Full Text] [Related]  

  • 10. The excretion of 5-hydroxyindoleacetic acid in the heterozygous carrier for phenylketonuria.
    HSIA DY; ROWLEY WA; HUANG I
    J Ment Defic Res; 1961 Jun; 5():4-9. PubMed ID: 13716364
    [No Abstract]   [Full Text] [Related]  

  • 11. Saturation of blood brain barrier transport of amino acids in phenylketonuria.
    Oldendorf WH
    Arch Neurol; 1973 Jan; 28(1):45-8. PubMed ID: 4734147
    [No Abstract]   [Full Text] [Related]  

  • 12. [Phenylalanine and tyrosine in albino rat brain in the normal state and in experimental phenylketonuria].
    Kaplanskiĭ SIa; Akopian ZhI
    Ukr Biokhim Zh; 1967; 39(1):34-7. PubMed ID: 5628879
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on phenylketonuria. IX. Further observations on the effect of phenylalanine-restricted diet on patients with phenylketonuria.
    ARMSTRONG MD; LOW NL; BOSMA JF
    Am J Clin Nutr; 1957; 5(5):543-54. PubMed ID: 13469756
    [No Abstract]   [Full Text] [Related]  

  • 14. Relative inability of mother and child to convert phenylalanine of tyrosine--a possible cause of nonspecific mental retardation.
    Fujimoto A; Crawford R; Bessman SP
    Biochem Med; 1979 Jun; 21(3):271-6. PubMed ID: 496920
    [No Abstract]   [Full Text] [Related]  

  • 15. The metabolism of indole-compounds in phenvlketonuria.
    HSIA DY; HUANG I
    Cereb Palsy Bull; 1961 Jun; 3():237-43. PubMed ID: 13716363
    [No Abstract]   [Full Text] [Related]  

  • 16. Excretion of phenylalanine and derivatives in phenylpyruvic oligophrenia.
    JERVIS GA
    Proc Soc Exp Biol Med; 1950 Oct; 75(1):83-6. PubMed ID: 14797744
    [No Abstract]   [Full Text] [Related]  

  • 17. The problem of phenylketonuria.
    PACHMAN DJ
    Chic Med; 1961 Jun; 63():20. PubMed ID: 13731930
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of phenylpyruvic oligophrenia].
    WOLF H
    Medizinische; 1956 Jun; (24):883-6. PubMed ID: 13347861
    [No Abstract]   [Full Text] [Related]  

  • 19. Possible biochemical model for phenylketonuria.
    Bowden JA; McArthur CL
    Nature; 1972 Jan; 235(5335):230. PubMed ID: 4551128
    [No Abstract]   [Full Text] [Related]  

  • 20. On the nature of enzymatic defect in phenylpyruvic oligophrenia.
    MITOMA C; AULD RM; UDENFRIEND S
    Proc Soc Exp Biol Med; 1957 Apr; 94(4):634-5. PubMed ID: 13431903
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.